Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial.
Saved in:
| Title: | Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial. |
|---|---|
| Authors: | Kumar, Deepali1 (AUTHOR), Ison, Michael G2 (AUTHOR), Mira, Jean-Paul3 (AUTHOR), Welte, Tobias4 (AUTHOR), Hwan Ha, Jick5 (AUTHOR), Hui, David S6 (AUTHOR), Zhong, Nanshan7 (AUTHOR), Saito, Takefumi8 (AUTHOR), Katugampola, Laurie9 (AUTHOR), Collinson, Neil9 (AUTHOR), Williams, Sarah9 (AUTHOR), Wildum, Steffen10 (AUTHOR), Ackrill, Andrew9 (AUTHOR), Clinch, Barry9 (AUTHOR), Lee, Nelson1,11,12 (AUTHOR) nelsonls.lee@utoronto.ca |
| Source: | Lancet Infectious Diseases. May2022, Vol. 22 Issue 5, p718-730. 13p. |
| Database: | Academic Search Ultimate |
| ISSN: | 14733099 |
|---|---|
| DOI: | 10.1016/S1473-3099(21)00469-2 |
